Nusano Presenting at Industry Events in October

VALENCIA, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024.

Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

WHAT: Panel Discussion – Supply Chain Challenges and Controversies: Ac225 Availability, Pb212 Logistics, The Last Mile
WHO: Rohan Jain, Chief Commercial Officer
WHEN: 10:50 – 11:35 AM Eastern
October 8, 2024
WHERE: New York, NY


BioFuture (biofuture.com)

WHAT: Company Presentation – Nusano: Supplying the Fight Against Cancer and Enabling Innovation Across Industries
WHO: Chris Lowe, CEO
WHEN: 11:00 AM Eastern
October 29, 2024
WHERE: New York, NY


JonesResearch Radiopharma Day

WHAT: Panel Discussion – Isotope Supply & Logistics
WHO: Rohan Jain, Chief Commercial Officer
WHEN: 1:25 – 2:25 PM Eastern
October 29, 2024
WHERE: Virtual

In addition to these speaking events, Nusano will attend the European Association of Nuclear Medicine (EANM) conference in Hamburg, Germany on October 19-23, 2024.

Companies and investors wishing to request a meeting with Nusano leadership during these conferences should email info@nusano.com.

About Nusano
Nusano is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. For more, please visit www.nusano.com

Contacts

Staff

Recent Posts

Good Look: A Decade Redefining On-Demand Beauty and Building Toward Unicorn Potential

MIAMI, FL / ACCESS Newswire / January 8, 2026 / What began as a visionary…

3 hours ago

Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies

HOUSTON, Jan. 8, 2026 /PRNewswire/ -- Bionova Scientific LLC, an Asahi Kasei company and a…

6 hours ago

Doceree Emerges as Healthcare Marketing’s Most AI-Forward Technology Platform, Building Industry’s First Operating System for the AI Era

Company unifies its AI ecosystem under doceree.ai, launches five industry-first AI solutions, earns top global…

6 hours ago

Longevity “GOAT” Dr. Mark Hyman Joins Jane Fonda as Keynote Speaker for the 2026 Livelong Women’s Health Summit

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Livelong Media is proud to announce Dr. Mark…

6 hours ago

Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets

CHATTANOOGA, Tenn., Jan. 8, 2026 /PRNewswire/ -- Cleanova, a leading global manufacturer of advanced industrial filtration…

6 hours ago

Zifo at JPM Healthcare Conference 2026: Why Technology Alone Cannot Deliver the AI Promise

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- The life sciences industry is buzzing about AI's…

6 hours ago